Safety Profile and Efficacy of Biosea® Revive Serum for Hair Growth Through In Vitro Assessment and Clinical Evaluation

Excessive hair loss can negatively impact psychological well-being and personal appearance. Providing effective hair growth products containing natural ingredients to people with hair loss can solve this problem. This study investigates Biosea® Revive serum (BRS), a novel hair care product containing biotinoyl tripeptide-1 and Phyllanthus emblica fruit extract as the main ingredients, as a natural intervention for hair growth. Results from the in vitro study demonstrates that BRS not only increased human hair dermal papilla cell (HHDPC) cell proliferation, but also reduced reactive oxygen species generation and 5α-reductase expression when compared to the control group, with BRS showing similar effect to the positive control, minoxidil. In addition, a 90-day clinical trial with 40 participants (KMUHIRB-F(I)-20230125; approval date: 18 August 2023) was conducted to assess the effectiveness and safety of BRS. The results revealed that BRS can improve hair density and quality in both men and women participants, with a significant reduction in transepidermal water loss (TEWL) in women (p < 0.05). Moreover, there were no adverse effects on blood parameters or scalp irritation reported after BRS treatment. In conclusion, we suggest that BRS offers a safe and effective solution for improving hair follicle health and is suitable for long-term use.